
Osborne Head & Neck Institute | Los Angeles
Ryan F. Osborne, MD, Fellowship-Trained Head & Neck Surgical Oncologist
Medically Reviewed By: OHNI Clinical Staff · Last Updated: November 4, 2026
Overview
Parotid tumors arise within the parotid gland, the largest salivary gland located just in front of the ear. These tumors can be benign (non-cancerous) or malignant (cancerous).
Despite the high rate of benign tumors, management decisions must be made carefully due to the gland's close relationship with the facial nerve, which controls facial movement.
75–80%
of parotid tumors are benign
20–25%
are malignant12,11
Standard of Care

Clinical studies and guidelines consistently show that parotidectomy is the primary treatment for both benign and malignant parotid tumors, with emphasis on preserving the facial nerve⁰,⁶.
Even benign tumors can continue to grow over time, distort facial appearance, and compress nearby structures. Left untreated, they may become more difficult to remove.
Certain benign tumors, especially pleomorphic adenomas, carry a small but real risk of transforming into malignant tumors over time. Incomplete or delayed treatment can increase this risk¹.
While imaging and biopsy provide valuable information, definitive diagnosis often requires surgical removal and pathological examination.
Indications

If a parotid tumor is cancerous, surgery is almost always required. Treatment typically includes tumor removal, possible removal of surrounding tissue, and additional therapies such as radiation⁶,³.
Symptoms such as facial weakness, paralysis, or numbness are strong indicators of nerve involvement and possible malignancy. These cases require urgent surgical evaluation¹².
Tumors that grow quickly, cause pain, or affect function are more likely to require surgical intervention.
Strongly Recommended

The most common benign parotid tumor. Surgery is recommended due to continued growth, risk of recurrence if untreated, and potential for malignant transformation¹.
Some may be monitored, but surgery is often recommended if the tumor is growing, symptoms are present, or diagnosis is uncertain.
If imaging and biopsy cannot definitively determine whether a tumor is benign or malignant, surgery is typically recommended for definitive diagnosis.
Observation
Although surgery is the standard approach, there are select situations where it may be avoided or delayed.
Small tumors with no growth and no symptoms may be monitored with regular follow-up. However, this requires close observation.
Patients with significant medical conditions may not be ideal candidates. Observation or non-surgical management may be considered.
In older patients with slow-growing tumors and no symptoms, observation may be appropriate, but must be individualized.
Risks of Delay
Procedures
Removes the outer portion of the gland. Common for benign tumors.
Removes the entire gland. Used for larger or deeper tumors.
A less invasive technique that removes small benign-appearing parotid tumors without full facial nerve dissection, reducing complications while maintaining tumor control in selected cases⁵.
Risks
While surgery is generally safe, potential risks include:
Modern techniques, including facial nerve monitoring, have significantly reduced complication rates.
Specialist Care
Parotid surgery is highly specialized. Outcomes depend heavily on surgeon experience, surgical technique, and tumor characteristics.
Choosing an experienced parotid surgeon is critical for preserving facial nerve function, achieving complete tumor removal, and minimizing complications.
Modern Surgery
Surgical management of parotid tumors has evolved significantly. Modern approaches include:
These techniques aim to reduce morbidity, preserve function, and improve cosmetic outcomes. Parotidectomy is a well-established procedure, and like all surgery it carries risks, including facial nerve function, cosmetic outcomes and recovery time.
While not every parotid tumor requires immediate surgery, the majority do benefit from surgical removal. The goal is not only to eliminate the tumor but also to preserve facial function and prevent future complications.
Early evaluation, accurate diagnosis, and expert surgical care are essential for achieving the best outcomes. If you have been diagnosed with a parotid tumor, consulting a specialist is the most important step in determining the right treatment plan.
Patient Education
Most do. Surgery is the standard treatment for both benign and malignant tumors, although select cases may be monitored.
In some cases, yes, but most benign tumors are removed due to growth and recurrence risks.
The tumor may grow, become more difficult to treat, and in rare cases, become cancerous.
Not always. Some can be observed, but surgery is often recommended depending on symptoms and growth.
The decision is based on tumor type, size, growth rate, symptoms, and patient health.

Why Choose OHNI
Many patients assume the best care is found at large, well-known institutions. While these centers offer excellent care, they often operate within standardized systems shaped by regional training models.
At OHNI, Dr. Ryan Osborne offers something fundamentally different: a truly global perspective combined with highly personalized surgical care with experience across five continents, tailoring each procedure to the individual patient, not the system.
Experience across five continents, applying diverse surgical philosophies and techniques beyond standard U.S. training.
Specialized techniques like Extra-Capsular Dissection designed to minimize invasiveness while protecting the facial nerve.
Direct surgeon access, individualized treatment planning, and a focus on both medical outcomes and quality of life.
Patients consistently highlight clear communication, confident surgical decisions, and excellent functional results.
Whether addressing benign or malignant tumors, the goal remains consistent: effective treatment with preservation of function, appearance, and quality of life.
Contact the Osborne Head & Neck Institute for expert evaluation and surgical planning.